Prediction of Total Drug Clearance in Humans Using Animal Data: Proposal of a Multimodal Learning Method Based on Deep Learning.

Journal: Journal of pharmaceutical sciences
PMID:

Abstract

Research into pharmacokinetics plays an important role in the development process of new drugs. Accurately predicting human pharmacokinetic parameters from preclinical data can increase the success rate of clinical trials. Since clearance (CL) which indicates the capacity of the entire body to process a drug is one of the most important parameters, many methods have been developed. However, there are still rooms to be improved for practical use in drug discovery research; "improving CL prediction accuracy" and "understanding the chemical structure of compounds in terms of pharmacokinetics". To improve those, this research proposes a multimodal learning method based on deep learning that takes not only the chemical structure of a drug but also rat CL as inputs. Good results were obtained compared with the conventional animal scale-up method; the geometric mean fold error was 2.68 and the proportion of compounds with prediction errors of 2-fold or less was 48.5%. Furthermore, it was found to be possible to infer the partial structure useful for CL prediction by a structure contributing factor inference method. The validity of these results of structural interpretation of metabolic stability was confirmed by chemists.

Authors

  • Hiroaki Iwata
    Division of School of Health Science, Department of Biological Regulation, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
  • Tatsuru Matsuo
    Artificial Intelligence Laboratory, Fujitsu Laboratories Ltd., 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan.
  • Hideaki Mamada
    Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.
  • Takahisa Motomura
    Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.
  • Mayumi Matsushita
    Fujitsu Kyushu Systems Ltd., 1-5-13, Higashihie, Hakata-ku, Fukuoka 812-0007, Japan.
  • Takeshi Fujiwara
    Dept. of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University.
  • Maeda Kazuya
    The University of Tokyo Graduate, School of Pharmaceutical Sciences, Department of Molecular Pharmacokinetics, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Koichi Handa
    Teijin Institute for Bio-medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino-shi, Tokyo 191-8512, Japan.